Press

If you are a member of the media and need help with a story or want to arrange an interview with an AABB spokesperson, please contact AABB’s Public Relations Department by emailing publicrelations@aabb.org or dialing +1.301.215.6526.

2022 Press Releases

Fresenius Kabi and AABB Celebrate 17th Annual Blood Collectors Week from Sept. 4-10

09/04/2022

Honoring blood collection professionals and their lifesaving impact on patient care
AABB Introduces New Biotherapies Credentialing Program

08/19/2022

The Association for the Advancement of Blood & Biotherapies (AABB) recently introduced the AABB Certified Advanced Biotherapies Professional (CABP) credentialing program. This is the first and only certification for biotherapies professionals.
AABB Appoints Sharon Carayiannis as Vice President, Science and Practice

03/18/2022

AABB is pleased to announce the appointment of Sharon Carayiannis, BSMT(ASCP)HP, as its vice president for Science and Practice. Carayiannis has served AABB in this role on an interim basis since October 2021.
AABB Launches New Alliance to Support the U.S. Blood Supply

02/04/2022

The Alliance for a Strong Blood Supply aims to improve the resilience of the blood supply.

2021 Press Releases

AABB Statement in Support of the Improving Access to Transfusion Care for Hospice Patients Act of 2021

07/30/2021

AABB applauds Senators Rosen, Barrasso and Baldwin for their bipartisan legislation to expand access to blood transfusion through the Improving Access to Transfusion Care for Hospice Patients Act of 2021.
AABB Appoints Linda S. Barnes as Vice President of Biotherapies

01/26/2021

AABB announced today the appointment of Linda S. Barnes, DrPHc, MHA, RAC (RAPS), as its Vice President, Biotherapies.

2020 Press Releases

AABB and IDSA Release Considerations for Clinicians on Emergency Use of COVID-19 Convalescent Plasma

12/15/2020

AABB and the Infectious Diseases Society of America issued today a resource document outlining considerations for clinicians on the use of COVID-19 convalescent plasma under the Emergency Use Authorization granted by the Food and Drug Administration
AABB Installs David Green as Association President During Virtual Annual Meeting

10/05/2020

AABB announced that David R. Green, MSA, began his term as President of the Association for the 2020-2021 term today, the last day of the 2020 AABB Virtual Annual Meeting.
Fresenius Kabi and AABB Celebrate 15th Annual Blood Collectors Week

09/06/2020

Fresenius Kabi and AABB are celebrating the 15th annual Blood Collectors Week September 6-12, 2020.
National Blood Foundation Announces 2020 Early-Career Grant Recipients

08/12/2020

AABB’s National Blood Foundation (NBF) announced today that it will be awarding eight early-career grants in 2020 to help fund innovative research in transfusion medicine and biotherapies.
AABB, ASCP Partner to Launch National Blood Donation Awareness Campaign

07/24/2020

AABB is partnering with the American Society for Clinical Pathology (ASCP) to launch a national campaign urging people to donate blood.
Racing Against Time, Medical Researchers, Life Science Companies and COVID-19 Survivors Launch National Campaign to Drive Blood Plasma Donation

05/26/2020

A coalition has come together to support the rapid development of potential new therapies for patients with COVID-19.
AABB Partnering with Survivor Corps to Facilitate COVID-19 Convalescent Plasma Donations

04/13/2020

AABB launched a new partnership with Survivor Corps, a grassroots organization connecting and mobilizing COVID-19 survivors with the scientific, medical and academic research community, to help increase treatment options for patients with COVID-19.
AABB Launches New Website to Inform Public About Convalescent Plasma

04/03/2020

AABB is launching today a new website as an educational resource to inform the public, blood collectors and clinicians about COVID-19 convalescent plasma (CCP).
“We Need People to Start Turning Out in Force to Give Blood”

03/12/2020

Over the past week, blood centers throughout the country are experiencing a significant drop in donations, which is limiting the ability for the nation’s blood supply to be adequately replenished.
Americans Urged to Donate Blood to Maintain Continued Adequacy of Blood Supply as Coronavirus Outbreak Continues

03/04/2020

As the coronavirus outbreak continues to spread in the United States, the AABB Interorganizational Task Force on Domestic Disasters and Acts of Terrorism is urging individuals to donate blood to ensure the continued adequacy of the blood supply.
AABB Joins Mayo Clinic Laboratories in Presenting “Transfuse 2020”

02/12/2020

AABB (formerly known as the American Association of Blood Banks) is partnering with Mayo Clinic Laboratories to present “Transfuse 2020,” which will be held May 12-13 in Rochester, MN.
AABB Commemorates 50th National Blood Donor Month with Blood Drive

01/14/2020

AABB (formerly known as the American Association of Blood Banks) is, once again, celebrating National Blood Donor Month (NBDM) by partnering with Inova Blood Donor Services to host a blood drive outside its National Office in Bethesda, Md.

2019 Press Releases

AABB Republishes Fourth Edition of Applied Blood Group Serology

10/08/2019

AABB announced today that it is republishing the fourth edition of Applied Blood Group Serology for a limited time.
Transfusion Medicine and Cellular Therapy Professionals Gather in San Antonio for 2019 AABB Annual Meeting

10/03/2019

The 2019 AABB Annual Meeting offers cutting-edge research, technological advances, continuing education and networking opportunities for professionals in the fields of transfusion medicine and cellular therapies.
AABB and IFATS Launch First Standards for Adipose-Based Therapies

10/01/2019

AABB and the International Federation for Adipose Therapeutics and Science (IFATS) announced today the launch of the 1st edition of Standards for Point of Care, Same Day Adipose Based Therapies.
AABB Launches Standards-Compliant Product Evaluation Program

09/06/2019

AABB announced today the launch of the AABB Standards-Compliant Product Evaluation (SCoPE) Program, an initiative designed to offer assurance that products for the blood community are in compliance with AABB standards.
AABB and Fresenius Kabi Celebrate 14th Annual Blood Collectors Week

09/03/2019

AABB and Fresenius Kabi are celebrating the 14th annual Blood Collectors Week September 1-7, 2019.
Public Urged to Donate Blood in Advance of Hurricane Dorian Making Landfall

08/30/2019

The AABB Interorganizational Task Force on Domestic Disasters and Acts of Terrorism is urging eligible blood donors in parts of the United States unaffected by the storm to make donation appointments as soon as possible and to keep existing appointments.
Transfusion Medicine and Cellular Therapy Trailblazers Receive AABB Memorial Awards

08/13/2019

AABB announced today the names of the transfusion medicine and cellular therapy leaders who will be receiving the Association’s 2019 Memorial Awards.
AABB’s National Blood Foundation Announces 2019 Early-Career Grant Recipients

07/23/2019

AABB’s National Blood Foundation (NBF) announced today the names of the six researchers who will be receiving NBF early-career grants in 2019.
AABB Issues Recommendations to Decrease Group O Blood Overuse

06/27/2019

In response to ongoing blood shortages in many regions of the United States, AABB this week released a series of recommendations to help blood collection facilities and hospitals decrease the overuse of group O blood.
AABB Hosting Blood Drive to Mark National Blood Donor Month

01/07/2019

AABB is partnering with Inova Blood Donor Services to host a mobile blood drive outside the AABB National Office in Bethesda, Md., on January 14, from 10:00 am to 2:00 pm, as part of its commitment to celebrate January as National Blood Donor Month.

2018 Press Releases

National Blood Foundation Awards 2018 Early-Career Grants to Seven Researchers

12/11/2018

AABB’s National Blood Foundation (NBF) announced today that it has awarded 2018 early-career scientific research grants to seven recipients.
Michael Murphy Installed as New President of AABB

10/16/2018

AABB (formerly known as the American Association of Blood Banks) has installed Michael Murphy, MD, FRCP, FRCPath, FFPath, as its president for the 2018-2019 term.
Infectious Disease Rates Higher Among MSM Blood Donors Compared with Overall Blood Donor Population

10/15/2018

The rate of infectious disease (ID) markers, such as those for HIV and hepatitis B and C viruses (HBV and HCV), in donated blood is higher for men who have sex with men (MSM) relative to blood donors overall.
Americans Urged to Donate Blood in Advance of Hurricane Florence

09/13/2018

The AABB Interorganizational Task Force on Domestic Disasters and Acts of Terrorism is urging eligible blood donors in parts of the United States unaffected by the storm to make donation appointments as soon as possible and keep existing appointments.
Fresenius Kabi and AABB Celebrate 13th Annual Blood Collectors Week

09/02/2018

Fresenius Kabi and AABB are celebrating Blood Collectors Week September 2-8, 2018.
AABB Announces 2018 Memorial Award Recipients

08/07/2018

AABB is pleased to announce the recipients of the 2018 Memorial Awards and Lectureships.
AABB Appoints Julia Zimmerman as Vice President, Membership, Meetings, Communications & Corporate Affairs

07/27/2018

AABB is pleased to announce the appointment of Julia Zimmerman as its Vice President, Membership, Meetings, Communications & Corporate Affairs.
National Blood Foundation Awarded Grant from Coastal Blood Foundation

07/23/2018

The National Blood Foundation has been awarded a $75,000 grant from the Coastal Blood Foundation to fund its early-career Scientific Research Grants Program.
AABB Now Offering Accreditation for Out-of-Hospital Transfusion Services

07/17/2018

AABB (formerly known as the American Association of Blood Banks) has recently unveiled a new accreditation offering for out-of-hospital transfusion services.
16th International Cord Blood Symposium Features Investigational Uses for Cord Blood Stem Cells

05/24/2018

Umbilical cord blood (UCB) has offered hope to thousands of patients since the first successful transplant in 1988 to treat Fanconi anemia.
Blood Community Executives to Address Industry Challenges at Leadership Forum

03/09/2018

AABB’s National Blood Foundation will convene executives in the fields of transfusion medicine, cellular therapies and patient blood management to discuss the pertinent issues currently affecting the blood community at the upcoming NBF Leadership Forum.
AABB Names Debra BenAvram Chief Executive Officer

02/22/2018

AABB, the leading organization representing the transfusion medicine and cellular therapy communities, announced today that it has appointed Debra BenAvram, FASAE, CAE, as its new Chief Executive Officer (CEO), effective June 1.